PT-141
For Research Use Only
Injectable
PT-141 works through the melanocortin system in the brain — a pathway distinct from how most sexual-wellness approaches function — supporting desire and arousal signaling centrally rather than through blood flow. It's FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women, giving it genuine regulatory and clinical standing. Because its mechanism is central rather than vascular, it represents a fundamentally different approach than more familiar options. Commonly used for: libido and sexual wellness support
Size: 10mg
$125.00
In stockCheckout opens once payment is connected.
Certificates of analysis
No certificate has been published for this product yet.
Research guides
- PT-141 (Bremelanotide) and Melanocortin Receptor Signalling: A Research OverviewA citation-indexed survey of the published literature on PT-141 (bremelanotide), a synthetic alpha-MSH analogue characterised as an agonist at melanocortin receptors MC3R and MC4R, covering receptor pharmacology, preclinical models, and the human trial record.
This product is not for human or animal consumption. Misuse of this product is illegal.